FDA NDC Directory · JSON-LD · Markdown

TAKHZYRO

NDC 47783-646 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namelanadelumab-flyo
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA761090
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsLANADELUMAB (300 mg/2mL)
Marketing started20220208
Package count1

External sources

Source: openFDA. Public-domain (CC0).